Trial Profile
A study of treat-and-extend regimen of intravitreal aflibercept injections in patients with polypoidal choroidal vasculopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 03 Apr 2017 New trial record
- 01 Mar 2017 Results published in the Japanese Journal of Ophthalmology